• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微转移灶的多细胞剂量测定:细胞核的自剂量与交叉剂量对辐射类型和能量以及放射性核素亚细胞分布的依赖性。

Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides.

作者信息

Goddu S M, Rao D V, Howell R W

机构信息

Department of Radiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark 07103.

出版信息

J Nucl Med. 1994 Mar;35(3):521-30.

PMID:8113908
Abstract

UNLABELLED

In radioimmunotherapy, the treatment of bulk tumors by radionuclides that emit energetic beta particles is the preferred approach. However, for the eradication of small clusters of cancer cells, radionuclides that emit Auger electrons or alpha particles are considered to be advantageous because of their ability to deposit radiation energy locally. If such radionuclides are internalized by the cells, the total dose to the cell nuclei is thought to be primarily determined by the self-dose (dose to cell nucleus from activity within the cell) in comparison to the cross-dose (dose to the cell nucleus from activity in all other cells).

METHODS AND RESULTS

The self-dose-to-cross-dose ratios to the cell nucleus were calculated for different cluster sizes (26-400 microns) with monoenergetic electron and alpha particle sources distributed uniformly in different cell compartments (cell surface, cytoplasm, nucleus). Model calculations were also performed for several radionuclides (Auger, beta and alpha emitters). Absorbed fractions for sources of monoenergetic electron and alpha particles, distributed uniformly in small spheres (26-5000 microns), were also calculated along with S-values for a number of radionuclides.

CONCLUSIONS

When most of the cells in the cluster are labeled with beta or alpha emitters, the cross-dose component of the total dose is important irrespective of cluster size and subcellular source distribution and increases as the cluster size increases. The self-dose is always important for Auger emitters. When the self-dose is negligible, the mean absorbed dose to the cell nuclei is well represented by the mean dose to the micrometastasis.

摘要

未标注

在放射免疫治疗中,通过发射高能β粒子的放射性核素治疗大块肿瘤是首选方法。然而,对于根除小簇癌细胞,发射俄歇电子或α粒子的放射性核素被认为具有优势,因为它们能够在局部沉积辐射能量。如果此类放射性核素被细胞内化,与交叉剂量(来自所有其他细胞活性对细胞核的剂量)相比,细胞核的总剂量被认为主要由自剂量(来自细胞内活性对细胞核的剂量)决定。

方法与结果

针对不同簇大小(26 - 400微米),计算了单能电子和α粒子源均匀分布在不同细胞区室(细胞表面、细胞质、细胞核)时细胞核的自剂量与交叉剂量之比。还对几种放射性核素(俄歇、β和α发射体)进行了模型计算。还计算了均匀分布在小球体(26 - 5000微米)中的单能电子和α粒子源的吸收分数以及多种放射性核素的S值。

结论

当簇中的大多数细胞用β或α发射体标记时,无论簇大小和亚细胞源分布如何,总剂量的交叉剂量成分都很重要,并且随着簇大小的增加而增加。自剂量对俄歇发射体始终很重要。当自剂量可忽略不计时,细胞核的平均吸收剂量可以很好地用微转移灶的平均剂量来表示。

相似文献

1
Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides.微转移灶的多细胞剂量测定:细胞核的自剂量与交叉剂量对辐射类型和能量以及放射性核素亚细胞分布的依赖性。
J Nucl Med. 1994 Mar;35(3):521-30.
2
Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments.细胞剂量学:单能电子和α粒子源的吸收分数以及放射性核素在不同细胞区室中均匀分布的S值。
J Nucl Med. 1994 Feb;35(2):303-16.
3
Comparison of different classes of radionuclides for potential use in radioimmunotherapy.用于放射免疫治疗的不同类别放射性核素的潜在用途比较。
Hell J Nucl Med. 2007 May-Aug;10(2):82-8.
4
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.放射免疫治疗中红骨髓剂量测定的研究:关于β射线、俄歇/转换电子或α射线发射体治疗中影响辐射诱导骨髓毒性因素的实验研究。
Clin Cancer Res. 1999 Oct;5(10 Suppl):3031s-3043s.
5
Absorbed fractions for electrons and beta particles in spheres of various sizes.不同尺寸球体中电子和β粒子的吸收分数。
J Nucl Med. 1994 Jan;35(1):152-6.
6
Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.用于全身肿瘤治疗的放射性核素的剂量学特征:粒子射程、光子发射和亚细胞分布的影响
Med Phys. 2006 Sep;33(9):3260-9. doi: 10.1118/1.2229428.
7
Monte Carlo single-cell dosimetry of Auger-electron emitting radionuclides.蒙特卡罗单细胞剂量学在电子俘获型放射性核素中的应用。
Phys Med Biol. 2010 May 7;55(9):2555-72. doi: 10.1088/0031-9155/55/9/009. Epub 2010 Apr 14.
8
Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics.
Phys Med Biol. 2008 Apr 7;53(7):1909-20. doi: 10.1088/0031-9155/53/7/007. Epub 2008 Mar 11.
9
Modeling dose deposition and DNA damage due to low-energy β(-) emitters.低能β(-)发射体所致剂量沉积与DNA损伤的建模
Radiat Res. 2014 Sep;182(3):322-30. doi: 10.1667/RR13664.1. Epub 2014 Aug 12.
10
Dose point kernel simulation for monoenergetic electrons and radionuclides using Monte Carlo techniques.使用蒙特卡罗技术对单能电子和放射性核素进行剂量点核模拟。
Radiat Prot Dosimetry. 2012 Nov;152(1-3):119-24. doi: 10.1093/rpd/ncs204. Epub 2012 Aug 23.

引用本文的文献

1
Impact of intracellular radionuclide distribution in a Monte Carlo biophysical 3D multi-cellular model for targeted alpha therapy.蒙特卡罗生物物理三维多细胞模型中细胞内放射性核素分布对靶向α治疗的影响。
Med Phys. 2025 Jul;52(7):e17917. doi: 10.1002/mp.17917.
2
Evaluation of relative biological effectiveness of Ac and its decay daughters with Monte Carlo track structure simulations.利用蒙特卡罗径迹结构模拟评估锕及其衰变子体的相对生物有效性。
EJNMMI Phys. 2025 Jul 7;12(1):65. doi: 10.1186/s40658-025-00765-0.
3
Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells.
由于造血干细胞和祖细胞上存在谱系依赖性生长抑素受体表达,神经内分泌肿瘤中放射治疗诊断概念的局限性。
Theranostics. 2025 May 25;15(13):6497-6515. doi: 10.7150/thno.113354. eCollection 2025.
4
Therapeutic evaluation of [Pb]Pb-AB001 and [Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer.[铅]铅-AB001和[镥]镥-PSMA-617在播散性前列腺癌小鼠模型中的治疗评估。
Eur J Nucl Med Mol Imaging. 2025 May 21. doi: 10.1007/s00259-025-07330-y.
5
A GATE simulation study for dosimetry in cancer cell and micrometastasis from the Ac decay chain.关于Ac衰变链在癌细胞和微转移中剂量测定的GATE模拟研究。
EJNMMI Phys. 2023 Aug 1;10(1):46. doi: 10.1186/s40658-023-00564-5.
6
Large-scale in vitro microdosimetry via live cell microscopy imaging: implications for radiosensitivity and RBE evaluations in alpha-emitter radiopharmaceutical therapy.通过活细胞显微镜成像进行大规模体外微剂量测定:对α发射体放射性药物治疗中放射敏感性和相对生物效应评估的影响
J Transl Med. 2023 Feb 24;21(1):144. doi: 10.1186/s12967-023-03991-1.
7
Dosimetry in Radiopharmaceutical Therapy.放射性药物治疗中的剂量学。
J Nucl Med. 2022 Oct;63(10):1467-1474. doi: 10.2967/jnumed.121.262305.
8
Predicting response of micrometastases with MIRDcell V3: proof of principle with Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids.使用 MIRDcell V3 预测微转移灶的反应:用 Ac-DOTA 包封脂质体在肿瘤球体中产生不同的活性分布来证明原理。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):3989-3999. doi: 10.1007/s00259-022-05878-7. Epub 2022 Jul 8.
9
MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling.MIRD 简讯第 27 号:MIRDcell V3,用于多细胞剂量学和生物效应建模的修订软件工具。
J Nucl Med. 2022 Sep;63(9):1441-1449. doi: 10.2967/jnumed.121.263253. Epub 2022 Feb 10.
10
Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy.克服放射性药物治疗(RPT)的障碍:NRG-美国国立癌症研究所放射性药物治疗剂量学工作组概述
Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):905-912. doi: 10.1016/j.ijrobp.2020.12.002. Epub 2020 Dec 10.